Monday , December 18 2017
Home / Steven V. Edelman, M.D.

Steven V. Edelman, M.D.

Steven V. Edelman, M.D.

Dr. Edelman is the founder and director of Taking Control of Your Diabetes (TCOYD), a not-for-profit 501(c)3 diabetes education organization founded in 1995. He is committed to promoting education, motivation and self-advocacy for people living with diabetes.

Board Certified in Internal Medicine, Endocrinology & Metabolism, Dr. Edelman currently serves as Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California at San Diego and the Veterans Affairs Healthcare System of San Diego. He is the Director of the Diabetes Care Clinic VA Medical Center and the Editor of the journals Insulin and Diabetes, Obesity and the Metabolic Syndrome. His research and publication history is extensive with over 200 articles and 5 books. In 2009, the American Diabetes Association recognized Dr. Edelman with the Outstanding Educator in Diabetes Award.

Dr. Edelman graduated as the valedictorian from the University of California at Davis Medical School. He completed an Internal Medicine Residency at UCLA and Clinical Fellowships in Diabetes and Metabolism at the Joslin and Lahey Clinics in Boston, as well as a research fellowship at the University of California at San Diego.

Autonomy Trial

se-insulin-2014-hs

The First Randomized Trial Comparing Two Patient-driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes In this Homerun Slides series, courtesy of Dr. Steven Edelman, on the AUTONOMY Trial we get an inside look at the groundbreaking results and conclusions that can be drawn from the patient driven …

Read More »

Steven V. Edelman, MD, Founder, TCOYD, Introduction

Steve Freed introduces Dr. Edelman who tells us about the Taking Control of Your Diabetes (TCOYD) programs which began in 1985 and now are up to 12 conventions a year, a TV show, a website, and a book, helping to bring diabetes education to millions of diabetes patients each year. More videos …

Read More »

Steven V. Edelman, MD: Perceived versus Actual Blood Sugars

Edelman

Dr. Steven V. Edelman discusses the results of a study he and his team did with patients to see how their perception of their blood sugars varied from their actual results. The results, he says, reinforce the idea of “Test, Don’t Guess.” Many patients said they could “feel” what their blood sugar was …

Read More »

Steven V. Edelman, MD, Q4 TCOYD Update

Dr. Edelman gives us an update on the TCOYD programs for 2012-2012 including; the fact that they are getting bigger each year with about 1500 people at each convention now; the type 1 track will be starting much earlier in the day this year with more special sessions; and the TCOYD …

Read More »

Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 15, Pt 5

Diagnosis_and_Management_of_Type_2_Diabetes

Long-Term Complications and Treatments Steve V. Edelman, MD Robert R. Henry, MD Microvascular Complications (cont’d) Gastroparesis This neuropathy should be suspected in patients with nausea, vomiting, early satiety, abdominal distention, and bloating following a meal, and is secondary to delayed emptying and retention of gastric contents. The delay in gastric emptying …

Read More »

Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 15, Pt 4

Diagnosis_and_Management_of_Type_2_Diabetes

Long-Term Complications and Treatments Steve V. Edelman, MD Robert R. Henry, MD Microvascular Complications (cont’d) Treatment for Diabetic Nephropathy Treatment is aimed at early detection and prevention, focusing specifically on improving glycemic control, aggressively treating hypertension (e.g., with ACE inhibitor or ARB therapy and other agents as necessary), and restricting …

Read More »

Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 15, Pt3

Diagnosis_and_Management_of_Type_2_Diabetes

Long-Term Complications and Treatments Steve V. Edelman, MD Robert R. Henry, MD Microvascular Complications Retinopathy, nephropathy, and neuropathy are the major microvascular complications of Type 2 diabetes. Prevention, early detection, and aggressive treatment are essential to reduce associated morbidity and mortality. Good metabolic control has been clearly shown to prevent the …

Read More »